Literature DB >> 15560498

Analysis of conformational change of human serum albumin using chiral capillary electrophoresis.

Hui Xu1, Xiao-Dong Yu, Hong-Yuan Chen.   

Abstract

The conformational change of human serum albumin (HSA) was studied through its binding with basic drug-mexiletine by chiral capillary electrophoresis. The effects of the conformational change of HSA resulted from pH, thermal, acute vibration, and alcohol on its chiral selectivity to mexiletine were investigated in detail. This study offers a simple and complementary method to investigate the binding of proteins with drugs and the characteristic of conformational change of protein. The method is easy to perform, high speed, low reagent consumption, and no modification is required to the commercially available CE instrument.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15560498     DOI: 10.1016/j.chroma.2004.09.025

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  ELISA assays and alcohol: increasing carbon chain length can interfere with detection of cytokines.

Authors:  Kristine von Maltzan; Stephen B Pruett
Journal:  Alcohol       Date:  2010-09-16       Impact factor: 2.405

Review 2.  Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: A review.

Authors:  Chenhua Zhang; Ashley G Woolfork; Kyungah Suh; Susan Ovbude; Cong Bi; Marawan Elzoeiry; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2019-09-12       Impact factor: 3.935

Review 3.  Recent applications of affinity interactions in capillary electrophoresis.

Authors:  Christian Schou; Niels H H Heegaard
Journal:  Electrophoresis       Date:  2006-01       Impact factor: 3.535

4.  Chiral Discrimination of Mexiletine Enantiomers by Capillary Electrophoresis Using Cyclodextrins as Chiral Selectors and Experimental Design Method Optimization.

Authors:  Melania Cârcu-Dobrin; Gabriel Hancu; Lajos Attila Papp; Ibolya Fülöp
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.